159 related articles for article (PubMed ID: 8590978)
1. Potent agonist action of 2-thioether derivatives of adenine nucleotides at adenylyl cyclase-linked P2Y-purinoceptors.
Boyer JL; O'Tuel JW; Fischer B; Jacobson KA; Harden TK
Br J Pharmacol; 1995 Nov; 116(6):2611-6. PubMed ID: 8590978
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of P2-purinoceptor antagonists on phospholipase C- and adenylyl cyclase-coupled P2Y-purinoceptors.
Boyer JL; Zohn IE; Jacobson KA; Harden TK
Br J Pharmacol; 1994 Oct; 113(2):614-20. PubMed ID: 7834215
[TBL] [Abstract][Full Text] [Related]
3. Identification of potent P2Y-purinoceptor agonists that are derivatives of adenosine 5'-monophosphate.
Boyer JL; Siddiqi S; Fischer B; Romero-Avila T; Jacobson KA; Harden TK
Br J Pharmacol; 1996 Aug; 118(8):1959-64. PubMed ID: 8864529
[TBL] [Abstract][Full Text] [Related]
4. Identification of potent, selective P2Y-purinoceptor agonists: structure-activity relationships for 2-thioether derivatives of adenosine 5'-triphosphate.
Fischer B; Boyer JL; Hoyle CH; Ziganshin AU; Brizzolara AL; Knight GE; Zimmet J; Burnstock G; Harden TK; Jacobson KA
J Med Chem; 1993 Nov; 36(24):3937-46. PubMed ID: 8254622
[TBL] [Abstract][Full Text] [Related]
5. A molecularly identified P2Y receptor simultaneously activates phospholipase C and inhibits adenylyl cyclase and is nonselectively activated by all nucleoside triphosphates.
Boyer JL; Delaney SM; Villanueva D; Harden TK
Mol Pharmacol; 2000 Apr; 57(4):805-10. PubMed ID: 10727529
[TBL] [Abstract][Full Text] [Related]
6. Adenine nucleotide analogues locked in a Northern methanocarba conformation: enhanced stability and potency as P2Y(1) receptor agonists.
Ravi RG; Kim HS; Servos J; Zimmermann H; Lee K; Maddileti S; Boyer JL; Harden TK; Jacobson KA
J Med Chem; 2002 May; 45(10):2090-100. PubMed ID: 11985476
[TBL] [Abstract][Full Text] [Related]
7. Molecular recognition of modified adenine nucleotides by the P2Y(1)-receptor. 1. A synthetic, biochemical, and NMR approach.
Halbfinger E; Major DT; Ritzmann M; Ubl J; Reiser G; Boyer JL; Harden KT; Fischer B
J Med Chem; 1999 Dec; 42(26):5325-37. PubMed ID: 10639276
[TBL] [Abstract][Full Text] [Related]
8. Identification of a P2Y-purinergic receptor that inhibits adenylyl cyclase.
Boyer JL; Lazarowski ER; Chen XH; Harden TK
J Pharmacol Exp Ther; 1993 Dec; 267(3):1140-6. PubMed ID: 8263774
[TBL] [Abstract][Full Text] [Related]
9. 2-Thioether-5'-O-(1-thiotriphosphate)-adenosine derivatives: new insulin secretagogues acting through P2Y-receptors.
Fischer B; Shahar L; Chulkin A; Boyer JL; Harden KT; Gendron FP; Beaudoin AR; Chapal J; Hillaire-Buys D; Petit P
Isr Med Assoc J; 2000 Jul; 2 Suppl():92-8. PubMed ID: 10909425
[TBL] [Abstract][Full Text] [Related]
10. Activity of adenosine diphosphates and triphosphates on a P2Y(T) -type receptor in brain capillary endothelial cells.
Simon J; Vigne P; Eklund KM; Michel AD; Carruthers AM; Humphrey PP; Frelin C; Barnard EA
Br J Pharmacol; 2001 Jan; 132(1):173-82. PubMed ID: 11156575
[TBL] [Abstract][Full Text] [Related]
11. Differential coupling of the human P2Y(11) receptor to phospholipase C and adenylyl cyclase.
Qi AD; Kennedy C; Harden TK; Nicholas RA
Br J Pharmacol; 2001 Jan; 132(1):318-26. PubMed ID: 11156592
[TBL] [Abstract][Full Text] [Related]
12. Second messenger cascade specificity and pharmacological selectivity of the human P2Y1-purinoceptor.
Schachter JB; Li Q; Boyer JL; Nicholas RA; Harden TK
Br J Pharmacol; 1996 May; 118(1):167-73. PubMed ID: 8733591
[TBL] [Abstract][Full Text] [Related]
13. The P2Y purinoceptor in rat brain microvascular endothelial cells couple to inhibition of adenylate cyclase.
Webb TE; Feolde E; Vigne P; Neary JT; Runberg A; Frelin C; Barnard EA
Br J Pharmacol; 1996 Dec; 119(7):1385-92. PubMed ID: 8968547
[TBL] [Abstract][Full Text] [Related]
14. ADP-evoked phospholipase C stimulation and adenylyl cyclase inhibition in glioma C6 cells occur through two distinct nucleotide receptors, P2Y(1) and P2Y(12).
Czajkowski R; Lei L; Sabała P; Barańska J
FEBS Lett; 2002 Feb; 513(2-3):179-83. PubMed ID: 11904146
[TBL] [Abstract][Full Text] [Related]
15. Agonists of the P2Y(AC)-receptor activate MAP kinase by a ras-independent pathway in rat C6 glioma.
Grobben B; Claes P; Van Kolen K; Roymans D; Fransen P; Sys SU; Slegers H
J Neurochem; 2001 Sep; 78(6):1325-38. PubMed ID: 11579141
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological and second messenger signalling selectivities of cloned P2Y receptors.
Nicholas RA; Lazarowski ER; Watt WC; Li Q; Boyer J; Harden TK
J Auton Pharmacol; 1996 Dec; 16(6):319-23. PubMed ID: 9131407
[TBL] [Abstract][Full Text] [Related]
17. Kinetics of activation of phospholipase C by P2Y purinergic receptor agonists and guanine nucleotides.
Boyer JL; Downes CP; Harden TK
J Biol Chem; 1989 Jan; 264(2):884-90. PubMed ID: 2910869
[TBL] [Abstract][Full Text] [Related]
18. Fidelity in functional coupling of the rat P2Y1 receptor to phospholipase C.
Schachter JB; Boyer JL; Li Q; Nicholas RA; Harden TK
Br J Pharmacol; 1997 Nov; 122(6):1021-4. PubMed ID: 9401764
[TBL] [Abstract][Full Text] [Related]
19. Identification of competitive antagonists of the P2Y1 receptor.
Boyer JL; Romero-Avila T; Schachter JB; Harden TK
Mol Pharmacol; 1996 Nov; 50(5):1323-9. PubMed ID: 8913364
[TBL] [Abstract][Full Text] [Related]
20. Two subtypes of G protein-coupled nucleotide receptors, P2Y(1) and P2Y(2) are involved in calcium signalling in glioma C6 cells.
Sabala P; Czajkowski R; Przybyłek K; Kalita K; Kaczmarek L; Barańska J
Br J Pharmacol; 2001 Jan; 132(2):393-402. PubMed ID: 11159687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
